Artificial intelligence programs reviewed tens of thousands of human drug studies, found a pattern tied to success, and proposed a lung cancer design later taken up by a manufacturer.

Scientists used AI to generate 16 viable viruses not found in nature, marking a first that experts say demands urgent safeguards against dual-use risks.

EPFL researchers activate three genes in memory neurons to reverse age-related decline and improve recall in models of Alzheimer's disease, offering new hope for brain health.

InnoCare's TYK2 inhibitor soficitinib hits vitiligo Phase 2 endpoint, advancing to Phase 3. Competitive autoimmune skin disorder trial shows strong F-VASI improvement.

AI-driven drug discovery is transforming biotechnology as Big Tech acquires biotech startups, redefining pharmaceutical innovation and the future of AI-powered healthcare.

Ambros and Ruvkun discovered microRNA, tiny RNA molecules that play a crucial role in gene regulation

Researchers in computational protein design and protein structure prediction assisted by AI have won the Nobel Prize in Chemistry.

Deo Fernaly discusses biotechnology's boundless horizons and explores the science, applications, and ethical dilemmas fueling a revolution in health, agriculture, and conservation.

Attaching future nanoscale components (such as brain electrodes, antennas and circuits) to living tissue or organisms

Researchers create unique DNA identifiers to verify and protect engineered cells, reducing errors and theft in biomedical studies.